Skip to Main Content

Paper Details

A novel chiral oxazoline copper(II)-based complex inhibits ovarian cancer growth <i>in vitro</i> and <i>in vivo</i> by regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors.
Dalton Trans
0
2023
Author NameAffiliation
Rong FanGuilin Medical University
  • 1 - 1

Datasets

Release 1.2